ゴーシェ病治療薬の世界市場2015-2019...市場調査レポートについてご紹介

【英文タイトル】Global Gaucher Disease Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Disease Overview
06.1 Understanding the Disease
06.1.1 Types of Gaucher Disease
06.1.2 Symptoms
06.1.3 Diagnosis
06.2 Etiology
06.3 Epidemiology
06.4 Clinical Manifestations
06.5 Management
06.5.1 Enzyme Replacement Therapy
06.5.2 Substrate Reduction Therapy
06.6 Economic Burden

07.Pipeline Analysis

08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis

09.Market Segmentation by Type of Therapy
09.1 Enzyme Replacement Therapy
09.2 Substrate Reduction Therapy

10 Market Segmentation by Type of Molecule
10.1 Biologics
10.2 Small Molecules

11 Market Segmentation by Route of Administration
11.1 Oral
11.2 Parenteral

12 Market Segmentation by Dosage Form
12.1 Solid
12.2 Liquid

13 Geographical Segmentation

14 Buying Criteria

15 Market Growth Drivers

16 Drivers and their Impact

17 Market Challenges

18 Impact of Drivers and Challenges

19 Market Trends

20 Trends and their Impact

21 Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.2.1 Genzyme
21.2.2 Shire
21.2.3 Actelion Pharmaceuticals
21.2.4 Pfizer
21.3 Other and Future Prominent Vendors

22 Key Vendor Analysis
22.1 Actelion Pharmaceuticals
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Geographical Segmentation 2013
22.1.4 Business Strategy
22.1.5 Recent Developments
22.1.6 SWOT Analysis
22.2 Genzyme
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Product Segmentation by Revenue 2013
22.2.4 Product Segmentation by Revenue 2012 and 2013
22.2.5 Geographical Segmentation
22.2.6 Business Strategy
22.2.7 Recent Developments
22.2.8 SWOT Analysis
22.3 Pfizer
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation by Revenue 2013
22.3.4 Business Segmentation by Revenue 2012 and 2013
22.3.5 Geographical Segmentation by Revenue
22.3.6 Business Strategy
22.3.7 Key Developments
22.3.8 SWOT Analysis
22.4 Shire
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Geographical Segmentation by Revenue 2013
22.4.4 Business Strategy
22.4.5 Recent Developments
22.4.6 SWOT Analysis

23 Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot of Gaucher Disease
Exhibit 3: Types of Gaucher Disease
Exhibit 4: Heredogram of Inheritance Pattern for Gaucher Disease
Exhibit 5: Clinical Manifestations of Gaucher Disease
Exhibit 6: Snapshot of Economic Burden of Gaucher Disease
Exhibit 7: Clinical Trials by Status (as of February 2015)
Exhibit 8: Clinical Trials by Phase (as of February 2015)
Exhibit 9: Snapshot of Global Gaucher Disease Market 2014
Exhibit 10: Global Gaucher Disease Market 2014-2019 (US$ million)
Exhibit 11: Drivers and Challenges of Global Gaucher Disease Market
Exhibit 12: Segmentation of Global Gaucher Disease Market by Type of Therapy
Exhibit 13: Segmentation of Global Gaucher Disease Market by Type of Therapy 2014
Exhibit 14: Segmentation of Global Gaucher Disease Market by Type of Molecule
Exhibit 15: Segmentation of Global Gaucher Disease Market by Type of Molecule 2014
Exhibit 16: Segmentation of Global Gaucher Disease Market by Route of Administration
Exhibit 17: Segmentation of Global Gaucher Disease Market by Route of Administration 2014
Exhibit 18: Segmentation of Global Gaucher Disease Market by Dosage Form
Exhibit 19: Segmentation of Global Gaucher Disease Market by Dosage Form 2014
Exhibit 20: Segmentation of Global Gaucher Disease Market by Geography 2014
Exhibit 21: Global Gaucher Disease Market Share Analysis 2014
Exhibit 22: Genzyme: Product Portfolio
Exhibit 23: Cerezyme: SWOT Analysis
Exhibit 24: Cerdelga: SWOT Analysis
Exhibit 25: Shire: Product Portfolio
Exhibit 26: Vpriv: SWOT Analysis
Exhibit 27: Actelion Pharmaceuticals: Product Portfolio
Exhibit 28: Zavesca: SWOT Analysis
Exhibit 29: Pfizer: Product Portfolio
Exhibit 30: Elelyso: SWOT Analysis
Exhibit 31: Actelion Pharmaceuticals: Geographical Segmentation by Revenue 2013
Exhibit 32: Genzyme: Product Segmentation by Revenue 2013
Exhibit 33: Genzyme: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 34: Genzyme: Geographical Segmentation
Exhibit 35: Pfizer: Business Segmentation by Revenue 2013
Exhibit 36: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 37: Pfizer: Geographical Segmentation by Revenue 2013
Exhibit 38: Shire: Geographical Segmentation by Revenue 2013


【レポート販売概要】

■ タイトル:ゴーシェ病治療薬の世界市場2015-2019
■ 英文:Global Gaucher Disease Market 2015-2019
■ 発行日:2015年3月18日
■ 調査会社:Technavio
■ 商品コード:IRTNTR5483
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。